Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790
Andreas Hald, Rikke Rie Hansen, Mette W Thomsen, Ming Ding, Peter I Croucher, Orla Gallagher, Frank H Ebetino, Moustapha Kassem, Anne-Marie Heegaard
17Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790'. Together they form a unique fingerprint.